InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Browse the detailed record of transactions filed by PAPADOPOULOS STELIOS, Director. Officer active across 3 companies, notably Exelixis, INC.. Aggregated, 11 filings have been recorded. Total volume traded: €1.5m. The latest transaction was filed on 15 June 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations11 total
02,255 shares0
Common Stock
SEC:0001127602-22-017806:0·
019,575 shares0
Common Stock
SEC:0000939767-22-000079:0·
€1m84,515 shares@ €17.2950.013% mcap77.9% of flow
Common Stock
SEC:0000939767-22-000031:0·
€708,3762,222,222 shares@ €0.3188100.0% of flow
Common Stock
SEC:0001209191-21-067264·
€708,3762,222,222 shares@ €0.318850.0% of flow
Common Stock
SEC:0001209191-21-067264:0·
01,275 shares0
Common Stock
SEC:0001127602-21-021336·
01,275 shares0
Common Stock
SEC:0001127602-21-021336:0·
016,424 shares0
Common Stock
SEC:0000939767-21-000063·
016,424 shares0
Common Stock
SEC:0000939767-21-000063:0·
€207,50140,000 shares@ €5.18750.0018% mcap100.0% of flow
Common Stock
SEC:0000939767-21-000049·
€207,50140,000 shares@ €5.18750.0018% mcap11.1% of flow
Common Stock
SEC:0000939767-21-000049:0·
11 of 11 declarations
About PAPADOPOULOS STELIOS
Stelios Papadopoulos serves as a Board Member at Exelixis, Inc., Biogen Inc., and Regulus Therapeutics Inc. With extensive experience in the biopharmaceutical sector, he contributes to the governance and strategy of these companies. His role is crucial in guiding strategic decisions and promoting innovation in the development of new treatments.
